ACTD logo

AlzChem Group BATS-CHIXE:ACTD Stock Report

Last Price

€44.15

Market Cap

€438.6m

7D

-0.6%

1Y

n/a

Updated

14 Jun, 2024

Data

Company Financials +

AlzChem Group AG

BATS-CHIXE:ACTD Stock Report

Market Cap: €438.6m

ACTD Stock Overview

Develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally.

ACTD fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance6/6
Financial Health6/6
Dividends3/6

AlzChem Group AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AlzChem Group
Historical stock prices
Current Share Price€44.15
52 Week High€0
52 Week Low€0
Beta1.02
1 Month Change-0.56%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO6.39%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

ACTDGB ChemicalsGB Market
7D-0.6%-5.4%-1.5%
1Yn/a-30.2%3.8%

Return vs Industry: Insufficient data to determine how ACTD performed against the UK Chemicals industry.

Return vs Market: Insufficient data to determine how ACTD performed against the UK Market.

Price Volatility

Is ACTD's price volatile compared to industry and market?
ACTD volatility
ACTD Average Weekly Movementn/a
Chemicals Industry Average Movement7.2%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.8%

Stable Share Price: ACTD has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ACTD's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19081,607Andreas Niedermaierwww.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.

AlzChem Group AG Fundamentals Summary

How do AlzChem Group's earnings and revenue compare to its market cap?
ACTD fundamental statistics
Market cap€438.60m
Earnings (TTM)€39.15m
Revenue (TTM)€543.40m

11.2x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACTD income statement (TTM)
Revenue€543.40m
Cost of Revenue€226.23m
Gross Profit€317.17m
Other Expenses€278.02m
Earnings€39.15m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 01, 2024

Earnings per share (EPS)3.85
Gross Margin58.37%
Net Profit Margin7.20%
Debt/Equity Ratio0%

How did ACTD perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

31%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.